Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
XETRA:EFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shandong Fengxiang Co Ltd
HKEX:9977
|
CN |
|
EDP Energias do Brasil SA
BOVESPA:ENBR3
|
BR |
|
N
|
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
|
CN |
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
Note Receivable
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
XETRA:EFF
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MLP SE
XETRA:MLP
|
Note Receivable
€3.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Mutares SE & Co KgaA
XETRA:MUX
|
Note Receivable
€11.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
95%
|
CAGR 10-Years
N/A
|
|
|
OVB Holding AG
XETRA:O4B
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DWS Group GmbH & Co KgaA
XETRA:DWS
|
Note Receivable
€82m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Ernst Russ AG
XETRA:HXCK
|
Note Receivable
€1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
Glance View
Deutsche Effecten & Wechsel Beteiligungs AG invests in companies, which focus on the areas of photonics and sensor systems, as well as biotechnology and information technology. The company is headquartered in Jena, Thueringen and currently employs 2 full-time employees. The company went IPO on 2010-04-29. The company concentrates on medium capitalized technology companies and supports them by equity capital, consults in corporate development and its sector network. The firm focuses its investments on companies operating primarily in the area of photonics and sensor systems. As of December 2011, the Company's portfolio consisted of Nanotron Technologies Ltd (engaged in wireless sensor networks, among others), IG Asset, Inc (engaged in the functional genome analysis), NOXXON Pharma AG (engaged in the development of pharmaceuticals on the basis of Spiegelmer technology)l, and iTAC Software (engaged in collaborative production management system for the discrete manufacturing industry). In June 2014, the Company acquired MueTec GmbH.
